Tumor-Infiltrating Lymphocyte Volume Is a Better Predictor of Disease-Free Survival Than Stromal Tumor-Infiltrating Lymphocytes in Invasive Breast Carcinoma.

CONCLUSIONS: Tumor-stroma ratio needs to be considered in estimation of tumor immunity, and TILV adds more predictive power to TILs.
PMID: 31305879 [PubMed - as supplied by publisher]

Source: American Journal of Clinical Pathology - July 14, 2019 Category: Pathology Authors: Vaziri Fard E, Ali Y, Wang XI, Saluja K, H Covinsky M, Wang L, Zhang S Tags: Am J Clin Pathol Source Type: research